Eli Lilly, Evidation Health, and Apple has released initial results from a feasibility study that reveals an iPhone, Apple Watch, iPad, and the Beddit sleep monitoring device, in combination with digital apps, may be able to differentiate people with mild cognitive impairment (MCI) and mild Alzheimer's disease dementia. The exploratory results were presented today at the Association for Computing Machinery's KDD conference in Anchorage, and are published on the conference website.Impact of
Read More
Yale, Mayo Clinic, Biofourmis Launches Research to Detect Heart Failure Using Wearable Biosensor Data
Biofourmis has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis' mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure to monitor functional capacity and quality of life to see if greater emphasis should be placed on these measures in the drug approval process.Impact of Heart FailureHeart failure afflicts approximately 6.5 million patients in the United States and
Read More
What’s the Difference: A Look at Consumer and Medical-Grade Wearables in Healthcare
Confirm Rx, the world's first smartphone compatible Insertable Cardiac Monitor (ICM)
Can both consumer and medical-grade wearables work together to fill healthcare’s care gaps? Dr. Sunil Kapur shares his insights.
What does Abbott’s Confirm Rx insertable cardiac monitor (ICM) and the latest Apple Watch have in common? The answer: more than you think, and perhaps not nearly enough. Today, consumer and medical-grade wearables may live in different markets, but they are aligning on a
Read More
Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores
One Drop, a digital blood glucose monitoring kit for diabetes management will now be available in select retail Apple stores, CNBC reports. Currently sold online in the Apple Store for $69.95, the digital diabetes kit includes a Bluetooth glucose meter, test strips, lancets (optional), and one year of free coaching from a certified diabetes coach.One Drop Blood Glucose MonitorOne Drop’s blood glucose meter ensures clinically proven accurate, reliable results in just five seconds. The meter then
Read More
Reaching the Healthcare Mainstream: Wearables and Remote Patient Monitoring Market Map
Even though 2014 was supposed to be the “year of the wearable” according to Forbes, five years later we are now seeing the wearable reach maturity and mass-adoption. This increase in adoption has largely been driven by software and hardware stability which is now allowing these devices to be used with confidence to manage an individual’s health and wellness, including chronic condition management. The graphic below from Accenture shows the increase in technology usage across consumers to manage
Read More
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
Cardiogram’s Wearable Based Monitoring Tool Is Now Covered by Oscar
Cardiogram is a digital health company announced that it's wearable-based monitoring for atrial fibrillation and diabetes is now covered by Oscar Health Insurance, without paying out of pocket. The coverage will help provide end-to-end preventive care: continuous wearable monitoring, convenient testing, contextualized results, and clinical triage.Impact of Chronic ConditionsFor chronic conditions like diabetes, atrial fibrillation, hypertension, and sleep apnea, anywhere between 20–80% of cases
Read More
March 2019 News, Merger & Acquisition, IPO, Public Company Performance Summary
A brief summary of noteworthy news, health IT M&A activity, IPOs, and public company performance during the month of March.
Noteworthy News
Amazon, JP Morgan, Berkshire Names New Joint Venture Haven
Amazon, J.P. Morgan, and Berkshire Hathaway name joint venture Haven. In January 2018, the three founding companies announced plans to create this independent organization, now called Haven, which is free from profit-making incentives and constraints. Haven’s focus is the 1.2 million
Read More
5 Groundbreaking Findings from the Stanford and Apple Heart Study
Stanford Medicine researchers recently released preliminary results of the Apple Heart Study, the largest study ever of its kind, which enrolled over 400,000 participants from all 50 states in a span of only eight months.
Apple Heart Study Overview
Presented at American College of Cardiology’s 68th Annual Scientific Session and Expo in New Orleans, the study was launched in 2017 to evaluate Apple Watch’s irregular rhythm notification, which occasionally checks the heart's rhythm in the
Read More
U of Michigan Launches 3-Year Health Data Collection Study Using Apple Watch
The University of Michigan has launched a three-year research study to understand if data collected on Apple Watch, combined with other health information, can provide insight into health, wellness, and disease. The goal of the research study is to understand the role of wearable mobile devices in predicting the onset of common health conditions and understanding the health trajectories of participants with these conditions.
MIPACT Study Background
The study called
Read More